📰 Abclonal Technology News
Abclonal Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abclonal Technology. Real-time updates on events, politics, business and more.
January 27, 2023
Media release DKSH Strengthens its Scientific Instrumentation Business by Partnering With ABclonal in Thailand DKSH has signed a new... | January 27, 2023
October 27, 2022
Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
May 18, 2022
We used rabbit embryos and oviduct fluid EVs as a model of embryo development, to examine the effect of loss or gain of EV functionality.
March 21, 2022
/PRNewswire/ -- ABclonal Technology, a rapidly growing life science research and diagnostic reagents manufacturer, today announced it has joined the Industry...
December 8, 2021
China Merchants Bank’s CMB International, and Lucion Venture Capital co-led the investment round.
June 11, 2021
ABclonal Technology products, product reviews and application articles on SelectScience.
May 11, 2021
The mechanism by which the LNC00115/miR-7/ERK axis promotes cisplatin resistance provides a new strategy for combating cisplatin resistance in ovarian cancer
March 5, 2021
Published: Mar 05, 2021 By Mark Terry Boston-based ABclonal Biotechnology acquiredcontract research organization (CRO) Yurogen Biosystems, headquartered in nearby Worcester, Massachusetts. Yurogen focuses on producing antibodies and antibody-based products for its clients. Its technology platform is a monoclonal antibody discovery program using single-B-cell-based SMab. This technology platform allows for high-throughput development of high-affinity, high-specificity monoclonal antibod...
March 5, 2021
ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide News provided by Share this article Share this article BOSTON, March 5, 2021 /PRNewswire/ -- ABclonal Biotechnology Co., Ltd., a global life science tools and services provider, acquires Yurogen Biosystems LLC, a contract research organization dedicated to monoclonal antibody discovery using single-B-cell-based SMab TM platform, to better serve researchers in in vitro diagnost...
February 22, 2021
/PRNewswire/ -- ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by...